PERCHLORACAP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Perchloracap, and when can generic versions of Perchloracap launch?
Perchloracap is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in PERCHLORACAP is potassium perchlorate. There are two hundred and forty drug master file entries for this compound. Additional details are available on the potassium perchlorate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PERCHLORACAP?
- What are the global sales for PERCHLORACAP?
- What is Average Wholesale Price for PERCHLORACAP?
Summary for PERCHLORACAP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Patent Applications: | 1,367 |
| DailyMed Link: | PERCHLORACAP at DailyMed |
US Patents and Regulatory Information for PERCHLORACAP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | PERCHLORACAP | potassium perchlorate | CAPSULE;ORAL | 017551-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
